Yakira Capital Management’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,013
Closed -$183 332
2023
Q3
$183 Hold
12,013
﹤0.01% 367
2023
Q2
$688 Hold
12,013
﹤0.01% 359
2023
Q1
$721 Sell
12,013
-12,931
-52% -$1.07K ﹤0.01% 376
2022
Q4
$1.65K Hold
24,944
﹤0.01% 358
2022
Q3
$10K Hold
24,944
﹤0.01% 362
2022
Q2
$14K Sell
24,944
-8,000
-24% -$7.88K ﹤0.01% 343
2022
Q1
$45K Sell
32,944
-38,556
-54% -$31.4K 0.01% 365
2021
Q4
$61K Sell
71,500
-9,000
-11% -$9.12K 0.01% 356
2021
Q3
$93K Sell
80,500
-13,000
-14% -$17.4K 0.01% 316
2021
Q2
$127K Hold
93,500
0.02% 299
2021
Q1
$103K Hold
93,500
0.02% 283
2020
Q4
$269K Buy
+93,500
New +$175K 0.06% 190

Other funds holding CELUW

Yakira Capital Management's CELUW Position: Q4 2023 in Review

Yakira Capital Management sold out of Celularity Inc (CELUW) in Q4 2023, closing a stake of 12,013 shares — an estimated $183 sold.

Yakira Capital Management first reported a position in CELUW in Q4 2020 and held it in 12 quarters. The position peaked at $269K in Q4 2020. 17 funds tracked by Wall St. Rank hold CELUW as of Q4 2023.

  • Yakira Capital Management reported no remaining Celularity Inc position as of Q4 2023 after selling out during the quarter.
  • Yakira Capital Management sold 12,013 Celularity Inc shares in Q4 2023, an estimated $183.
  • Yakira Capital Management first reported a position in Celularity Inc in Q4 2020 and held it in 12 quarters.
  • Yakira Capital Management's Celularity Inc position peaked at $269K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2023.

Based on Yakira Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.